"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Selected lectures that examine the intersection between sexual health and cardiovascular health, with a focus on the pharmacologic therapy for erectile dysfunction (ED). Lectures from US experts on the newest data on safety and cardiac interactions with PDE5 inhibitors, the workup for ED and associated cardiac risk factors in 2023, the role of CT Calcium scoring, the psychologic impact of ED, potential cardioprotective effects of PDE5 inhibitors, mechanism of action of PDE5 inhibitors, non-PDE5 inhibitor therapy for ED including restorative therapies (stem cell, shock wave therapy, platelet rich plasma), alternative therapies, PDE5 inhibitors in women, status of diagnostic and treatments for female sexual dysfunction.
Videos
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Cardiovascular Safety and Benefits of PDE-5 Inhibition in Women with Female Sexual Dysfunction (FSD): Summary of Findings from Clinical Trials of PDE-5 Inhibition in Women
FEATURING
Irwin Goldstein
- 62 views
- July 18, 2023
- 1
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Is ED an Independent Risk Factor or Risk Marker for Cardiovascular Disease and What Is the Role of CT Calcium Scoring?
FEATURING
Michael Blaha
- 1,171 views
- July 13, 2023
- 10
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Neurovascular Mechanisms in Female Sexual Arousal Disorders and Potential Targets in Women: Is There a Role for Topical or Oral PDE-5 Inhibition in Treating Female Sexual Dysfunction (FSD)?
FEATURING
Noel Kim
- 99 views
- July 11, 2023
- 3
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Recent Studies on Safety of PDE-5 Inhibitors with Antihypertensive Medicines and Nitrates: Should Nitrates Remain a Contraindication or Now Be Considered a Warning?
FEATURING
Peter Ganz
- 134 views
- July 11, 2023
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Potential Cardiovascular Benefits in the General Population of Men with ED, in Diabetics, in Men with Other Risk Factors: Are PDE-5 Inhibitors Cardioprotective?
FEATURING
Robert Kloner
- 418 views
- July 11, 2023
- 1
"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Huntington Medical Research Institutes, Pasadena, CA. Friday, March 10th, 2023.
Work-up of Young Men with ED: Do Younger Men with ED Have Greater Risk of Cardiovascular and All-Cause Mortality?
FEATURING
Tobias Kohler
- 252 views
- July 11, 2023
- 3